Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 6/20 | 0.56 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.56 |
| ▸ | CHRNB2 | P17787 | 6/20 | 0.53 |
| ▸ | CHRNA4 | P43681 | 6/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29932734 | 1.00 | CHRNB4 (0.56) | CHRNB4CHRNA3CHRNB2CHRNA4POLB | |
| SCHEMBL27594106 | 0.98 | CHRNB4 (0.58) | CHRNB4CHRNA3CHRNB2CHRNA4POLB | |
| SCHEMBL27057850 | 0.94 | CHRNB4 (0.58) | CHRNB4CHRNA3CHRNB2CHRNA4POLB | |
| SCHEMBL29998481 | 0.90 | CHRNB4 (0.61) | CHRNB4CHRNA3CHRNB2CHRNA4POLB | |
| SCHEMBL3060400 | 0.83 | CHRNB2 (0.68) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL2001588 | 0.82 | CHRNB4 (0.54) | CHRNB4CHRNA3CHRNB2CHRNA4POLB | |
| SCHEMBL29552004 | 0.81 | AKR1C3 (0.70) | CHRNB4CHRNA3CHRNB2CHRNA4POLB | |
| SCHEMBL2923088 | 0.81 | CHRNB2 (0.64) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL1321991 | 0.81 | AKR1C3 (0.54) | CHRNB4CHRNA3CHRNB2CHRNA4MAPT | |
| SCHEMBL5198623 | 0.81 | AKR1C3 (0.70) | CHRNB4CHRNA3CHRNB2CHRNA4POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003500402-A | — | — | 2003-01-07 | — | — | JP | claimed |
| EP-1178982-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2002-02-13 | — | — | EP | claimed |
| WO-2000071534-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2000-11-30 | — | — | WO | claimed |
| EP-1178982-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000071534-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2000-11-30 | — | — | WO | disclosed |